In accordance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it has enclosed the Proceedings of the Extraordinary General Meeting (EGM) of the Company held on June 29, 2021.
The above information is a part of company’s filings submitted to BSE.